Frontlight ResearchEarly access
Graves' disease trials in Italy
9 of 10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ItalyA Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Where
- Cagliari, Milan, Naples, Pisa, Rome
- Age
- 18 years to 75 years
- People
- 60 worldwide
- Run by
- Biogen
See details and how to joinNCT07722546 · EU 2026-526482-19-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Ancona, Bergamo, Genoa, Milan, Monserrato, Naples, Padova, Pisa, Rome, Varese
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Acquaviva delle Fonti, Bergamo, Cuneo, Leghorn, Milan, Naples, Pavia, Perugia, Pieve Emanuele, Rome, Turin, Udine
- Age
- 18 years to 75 years
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - Phase 2Taking peopleA Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
- Where
- Merano, Milan, Palermo, Pisa
- Age
- 18 years to 75 years
- People
- 30 worldwide
- Run by
- Sanofi
See details and how to joinNCT06984627 - Phase 2Active, not recruitingA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Bologna, Cagliari, Genoa, Milan, Naples, Pisa, Rome, Siena, Varese
- Age
- 18 years to 75 years
- People
- 240 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT06727604 · EU 2024-516020-33-00 - Phase 2Taking peopleA Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
- Where
- Acquaviva delle Fonti, Bergamo, Bologna, Cagliari, Cuneo, Genoa, Leghorn, Milan, Naples, Palermo, Pavia, Perugia, Pieve Emanuele, Pisa, Rome, Siena, Turin, Udine, Varese
- Age
- 18 years and over
- People
- 128 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to join2025-524001-33-00 - Phase 2Taking peopleStudy to Assess K1-70 in Participants with Active Thyroid Eye Disease
- Where
- Milan, Pisa, Varese
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Av7 Limited
See details and how to join2024-519292-26-00 - Phase 3Not yet taking people in ItalyA phase III, randomized, controlled, open label, no profit, single-center intervention study to compare the effect of a conservative (antithyroid drugs) and an ablative approach (radioiodine or total thyroidectomy) for the treatment of hyperthyroidism in patients with Graves’ disease and moderate-to-severe and active Graves’ Orbitopathy (GO) treated with intravenous glucocorticoids (ABLAGO Study)
- Where
- Pisa
- Age
- 18 years and over
- People
- 52
- Run by
- Azienda Ospedaliero Universitaria Pisana
See details and how to join2024-518452-23-00 - Phase 3Not yet taking people in ItalyA Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study
- Where
- Pisa
- Age
- 18 years to 75 years
- People
- 102
- Run by
- University of Pisa
See details and how to joinNCT05049603